Work

Targeting the 26S Proteasome To Protect Against Proteotoxic Diseases

Year: 2017

Type: review

Source: Trends in Molecular Medicine

DOI: 10.1016/j.molmed.2017.11.006

Authors: Natura Myeku, Karen E. Duff

Institutions: Columbia University Irving Medical Center, New York State Psychiatric Institute

Language: English

Topic: Ubiquitin and proteasome pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Cure Alzheimer's Fund, National Institutes of Health, National Institute on Aging

Awards: Tauopathy in AD and FTD - Molecular Determinants of Phenotypic Diversity, G5668615729, The Role of Synaptic Proteolysis in Alzheimer's Disease and Therapeutic Implications, Receptor-mediated clearance of synaptic tau as a novel therapy for Alzheimer's disease.

OpenAlex ID: W2773477944

FWCI: 0.537

Cites: 111

Cited by: 57

Related to: 10